Fig. 6From: MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancerrhMG53 enhances cisplatin-induced cell death in A549 cells. A Dose-dependent changes in A549 cell viability were established with incubation of cisplatin for 48 hours (closed circle) or 72 hours (open circle). B A549 cells were cultured in the presence of rhMG53 or rhMG53 plus cisplatin (5μM) at indicated doses for 48 hours. Data presented are mean ± SD of four duplicates each. *** P<0.001 for the indicated group. C Representative images of cells treated with cisplatin (5μM), rhMG53 (100μg/ml), or combination of rhMG53 and cisplatinBack to article page